Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.06 - $2.96 $28,634 - $41,144
13,900 Added 36.77%
51,700 $147,000
Q2 2024

Aug 15, 2024

BUY
$1.7 - $2.45 $27,030 - $38,955
15,900 Added 72.6%
37,800 $85,000
Q1 2024

May 07, 2024

SELL
$2.04 - $3.22 $219,096 - $345,828
-107,400 Reduced 83.06%
21,900 $48,000
Q4 2023

Feb 14, 2024

SELL
$1.47 - $2.36 $68,061 - $109,268
-46,300 Reduced 26.37%
129,300 $303,000
Q3 2023

Nov 14, 2023

BUY
$1.8 - $2.69 $14,760 - $22,058
8,200 Added 4.9%
175,600 $326,000
Q2 2023

Aug 11, 2023

BUY
$1.82 - $2.98 $218,764 - $358,196
120,200 Added 254.66%
167,400 $438,000
Q1 2023

May 16, 2023

SELL
$1.03 - $1.63 $237,312 - $375,552
-230,400 Reduced 83.0%
47,200 $76,000
Q4 2022

Feb 14, 2023

BUY
$1.14 - $1.65 $15,161 - $21,945
13,300 Added 5.03%
277,600 $369,000
Q3 2022

Nov 14, 2022

SELL
$1.37 - $1.93 $248,929 - $350,681
-181,700 Reduced 40.74%
264,300 $412,000
Q2 2022

Aug 15, 2022

SELL
$1.48 - $2.64 $80,068 - $142,824
-54,100 Reduced 10.82%
446,000 $687,000
Q1 2022

May 16, 2022

BUY
$2.0 - $2.87 $853,800 - $1.23 Million
426,900 Added 583.2%
500,100 $1.28 Million
Q4 2021

Feb 14, 2022

BUY
$1.8 - $2.93 $131,760 - $214,476
73,200 New
73,200 $214,000

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $464M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.